Drug intelligence / Profile preview

aspirin + phenacetin + caffeine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Zhitong San (止痛散) is a classic analgesic and antipyretic combination medication widely used in China, commonly referred to as APC powder. It is composed of three active pharmaceutical ingredients: aspirin, phenacetin, and caffeine. Aspirin and phenacetin function as nonsteroidal anti-inflammatory drugs (NSAIDs) that provide pain relief and reduce fever by inhibiting cyclooxygenase enzymes and subsequent prostaglandin synthesis. Caffeine is included as an adjuvant to enhance the analgesic efficacy of the NSAIDs and to provide a mild stimulant effect. While historically popular for the treatment of headaches, toothaches, and neuralgia, the use of Zhitong San has faced scrutiny due to the phenacetin component, which is associated with nephrotoxicity and urothelial carcinoma upon long-term use. Consequently, it has been largely superseded by safer combinations (such as those containing paracetamol) in many clinical guidelines, though it remains available in the Chinese market.

Brand names
Zhitong San止痛散
Other names
APC powderAspirin, Phenacetin and Caffeine Powder阿司匹林非那西丁咖啡因散Headache Powder头痛粉
02

Targets

ADORA2A (Adenosine A₂A Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)ADORA1 (Adenosine receptor A1 subtype)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on aspirin + phenacetin + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aspirin + phenacetin + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call